Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2) Antibody Responses in Children With Multisystem Inflammatory Syndrome in Children (MIS-C) and Mild and Severe Coronavirus Disease 2019 (COVID-19).
Journal: Journal Of The Pediatric Infectious Diseases Society
Published:
Abstract
Severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) antibody responses in children remain poorly characterized. Here, we show that pediatric patients with multisystem inflammatory syndrome in children (MIS-C) possess higher SARS-CoV-2 spike immunoglobulin G (IgG) titers compared with those with severe coronavirus disease 2019, likely reflecting a longer time since the onset of infection in MIS-C patients.
Authors
Elizabeth Anderson, Caroline Diorio, Eileen Goodwin, Kevin Mcnerney, Madison Weirick, Sigrid Gouma, Marcus Bolton, Claudia Arevalo, Julie Chase, Philip Hicks, Tomaz Manzoni, Amy Baxter, Kurt Andrea, Chakkapong Burudpakdee, Jessica Lee, Laura Vella, Sarah Henrickson, Rebecca Harris, E Wherry, Paul Bates, Hamid Bassiri, Edward Behrens, David Teachey, Scott Hensley
Relevant Conditions